Interactions of exendin-(9–39) with the effects of glucagon-like peptide-1-(7–36) amide and of exendin-4 on arterial blood pressure and heart rate in rats
暂无分享,去创建一个
[1] B. Thorens,et al. Expression of the Glucagon‐Like Peptide‐1 Receptor Gene in Rat Brain , 1996, Journal of neurochemistry.
[2] D. Smith,et al. A role for glucagon-like peptide-1 in the central regulation of feeding , 1996, Nature.
[3] B. Göke,et al. Characterisation of the processing by human neutral endopeptidase 24.11 of GLP-1(7–36) amide and comparison of the substrate specificity of the enzyme for other glucagon-like peptides , 1995, Regulatory Peptides.
[4] S. Mojsov,et al. Tissue‐specific expression of the human receptor for glucagon‐like peptide‐I: brain, heart and pancreatic forms have the same deduced amino acid sequences , 1995, FEBS letters.
[5] F. Mora,et al. Structural Characterization by Affinity Cross‐Linking of Glucagon‐Like Peptide‐1(7–36)Amide Receptor in Rat Brain , 1995, Journal of neurochemistry.
[6] B. Göke,et al. Reduction of the Incretin Effect in Rats by the Glucagon-Like Peptide 1 Receptor Antagonist Exendin (9–39) Amide , 1995, Diabetes.
[7] D. Smith,et al. Glucagon-like peptide-1 is a physiological incretin in rat. , 1995, The Journal of clinical investigation.
[8] E. Blázquez,et al. Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36) amide in rats. , 1994, The American journal of physiology.
[9] B. Göke,et al. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. , 1993, The Journal of biological chemistry.
[10] I. Valverde,et al. Presence and characterization of glucagon-like peptide-1(7-36) amide receptors in solubilized membranes of rat adipose tissue. , 1993, Endocrinology.
[11] G. Singhg,et al. Truncated glucagon-like peptide-1 interacts with exendin receptors on dispersed acini from guinea pig pancreas. Identification of a mammalian analogue of the reptilian peptide exendin-4. , 1992, The Journal of biological chemistry.
[12] F. Mora,et al. Selective release of glutamine and glutamic acid produced by perfusion of GLP-1(7–36) amide in the basal ganglia of the conscious rat , 1992, Brain Research Bulletin.
[13] J. Eng,et al. Exendin-3 and -4 are insulin secretagogues , 1992, Regulatory Peptides.
[14] J. Holst,et al. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. , 1992, The New England journal of medicine.
[15] J. Raufman,et al. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. , 1992, The Journal of biological chemistry.
[16] B. Göke,et al. Characterization of glucagon‐like peptide‐I(7–36)amide receptors of rat lung membranes by covalent cross‐linking , 1991, FEBS letters.
[17] E. Blázquez,et al. Characterization of high‐affinity receptors for truncated glucagon‐like peptide‐1 in rat gastric glands , 1990, FEBS letters.
[18] S. Bloom,et al. Characterization of glucagon-like peptide-1-(7–36)amide in the hypothalamus , 1989, Brain Research.
[19] S. Kanse,et al. Identification and characterization of glucagon‐like peptide‐1 7–36 amide‐binding sites in the rat brain and lung , 1988, FEBS letters.
[20] J. Lauder,et al. Distribution of glucagonlike peptide I (GLP‐I), glucagon, and glicentin in the rat brain: An immunocytochemical study , 1988, The Journal of comparative neurology.
[21] S. Bloom,et al. GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MAN , 1987, The Lancet.
[22] L. Orci,et al. Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. , 1986, The Journal of biological chemistry.
[23] T. Smitherman,et al. Cardiac dose response relationship for intravenously infused glucagon in normal intact dogs and men. , 1978, American heart journal.
[24] W. Schenk,et al. Hemodynamic Responses to Glucagon: An Experimental Study of Central, Visceral and Peripheral Effects , 1970, Annals of surgery.
[25] W. Parmley,et al. Cardiovascular effects of glucagon in man. , 1968, The New England journal of medicine.